|
|
| ¡ÃҿʶԵԸØáԨ | 5 |  | 2.50 |
| ÁÍ¡.574-2528 | 5 | | 2.50 |
| ËéͧÊÁØ´ã¹»ÃÐà·Èä·Â | 4 | | 2.00 |
| »ÃÐà·ÈËéͧÊÁØ´ã¹»ÃÐà·Èä·Â | 4 | | 2.00 |
| ¢èÒǡͧ¤Çº¤ØÁÍÒËÒà | 4 | | 2.00 |
| á¹Ç·Ò§¡Òûéͧ¡Ñ¹ÊÔ·¸Ô¢Í§¼ÙéºÃÔâÀ¤Çѵ¶ØÍѹµÃÒ | 3 | | 1.50 |
| µÒÃÒ§áÊ´§¤Ø³¤èÒ·Ò§âÀª¹Ò¡ÒâͧÍÒËÒÃä·Â | 3 | | 1.50 |
| ÊÃþ¤Ø³ ÂÒʵÃÕູâÅ à»ç¹ english | 3 | | 1.50 |
| ÁÍ¡ "»Ò¡¡ÒÊÕ¹éÓ" | 3 | | 1.50 |
| ÂÒ | 3 | | 1.50 |
| ¢éÍÁÙÅ gmp | 3 | | 1.50 |
| ¼éÒÊÕÊ´ÂéÍÁÊÕ¸ÃÃÁªÒµÔ»ÃÒȨҡÊÒþÔÉ | 3 | | 1.50 |
| »Ñ¨¨Ñ·ÕèÁռŵèͤسÀÒ¾àµéÒËÙéÂÕé | 2 | | 1.00 |
| ¢èÒǨҡ¡Í§¤Çº¤ØÁÍÒËÒà | 2 | | 1.00 |
| á¹Ç·Ò§¡ÒþѲ¹Ò¼ÅÔµÀѳ±ìÂÒÃٻẺ¢Í§á¢ç§ | 2 | | 1.00 |
| ËÅÑ¡¡ÒÃÇÔà¤ÃÒÐËìÍÒËÒà | 2 | | 1.00 |
| ÍÒ¡ÒÃäÁè¾Ö§»ÃÐʧ¤ì¨Ò¡¡ÒÃãªéÂÒÇѳâä | 2 | | 1.00 |
| ÇÒÃÊÒÃäÇÃÑÊ | 2 | | 1.00 |
| ͧ¤ì¡ÒÃÍÒËÒÃáÅÐÂÒ | 2 | | 1.00 |
| cisapride ÍÂ | 2 | | 1.00 |
| ÅѡɳТͧ¡ÃÐà·ÕÂÁ | 2 | | 1.00 |
| cisapride ÍÒËÒÃáÅÐÂÒ | 2 | | 1.00 |
| ËÁͨչÅÔ鹺͡âä | 2 | | 1.00 |
| ·ÄÉ®ÕâÍàÃçÁã¹¼èҵѴäÊéàÅ×è͹ | 2 | | 1.00 |
| ʶԵԡÒùÓà¢éÒÊÒÃà¤ÁÕà¡ÉµÃ | 2 | | 1.00 |
| àµ×͹ÀØÂÇÑÂÃØè¹ | 2 | | 1.00 |
| ÃÒÂÅÐàÍÕ´ÁÍ¡. 143-2518 ÁÒ¡ÒÃÕ¹ | 2 | | 1.00 |
| ÂÒâ¤à´ÍÔ¹¿ÔÁàÁç´¡ÅÁ | 2 | | 1.00 |
| Êӹѡ§Ò¹¤³Ð¡ÃÃÁ¡ÒÃÍÒËÒÃáÅÐÂÒ | 2 | | 1.00 |
| ¡ÒõÃǨÊͺ¨ØÅÔ¹·ÃÕÂìã¹ÍÒËÒõÒÁÊÑè§ | 2 | | 1.00 |
| ÁÍ¡.162-2541 | 2 | | 1.00 |
| ÊØÃÔ¹·Ãì ¾Ô¹Ô¨¾§Èì | 1 | | 0.50 |
| à¤Ã×èͧÁ×Íá¾·Âì¨Õ¹ | 1 | | 0.50 |
| ¡ÒúԹä·Â swot doc | 1 | | 0.50 |
| ä«âº·ÃÒÁÕ¹ | 1 | | 0.50 |
| áËÅ觷Õèà¡Ô´ÅÔÊ·ÕàÃÕ âÁâ¹ä«âµ¨Õà¹Ê | 1 | | 0.50 |
| ¢éÍÁÙÅ â«à´ÕÂÁ«Ñ¤ÅÒàÁµ | 1 | | 0.50 |
| ˹ѧÊ×ÍÍéÒ§ÍÔ§àÅèÁÅСÕèºÒ· | 1 | | 0.50 |
| ÂÒµÃÕ¹ÔÊÔ§àË ËÁÍÁÕ | 1 | | 0.50 |
| ·ÕèÁÒÅÔÊ·ÕàÃÕ âÁâ¹ä«âµ¨Õà¹Ê | 1 | | 0.50 |
| ¨Ø´Íè͹¢Í§ºÃÔÉÑ·¡ÒúԹä·Â | 1 | | 0.50 |
| ¾ÃÐÃÒª¡Ó˹´àÃ×èͧ©ÅÒ¡ÍÒËÒà | 1 | | 0.50 |
| swot¢Í§ºÃÔÉÑ·¡ÒúԹä·Â | 1 | | 0.50 |
| ÊÃþ¤Ø³ÍÒËÒÃÊÓËÃѺáÁèËÅѧ¤ÅÍ´ | 1 | | 0.50 |
| ¢èÒÇ¡ÃзÃǧÊÒ¸ÒóÊØ¢à¡ÕèÂǡѺ¡ÒÃÅÐàÁÔ´ÊÔ·¸Ô¼ÙéºÃÔâÀ¤ | 1 | | 0.50 |
| ºÃÔÉÑ·ºØËÃÕèàÅç§ËÔ§ä·Â | 1 | | 0.50 |
| ¼Å¡ÒÃÇÔ¨ÑÂÅÓäÂáË駨ҡÁËÒÇÔ·ÂÒÅÑÂàªÕ§ãËÁè â´Â ÃÈ.´Ã.ÍØɳÕÂì ÇԹԨࢵ | 1 | | 0.50 |
| nortriptyline ÀÒÉÒä·Â | 1 | | 0.50 |
| tua 360 ãªéä´é¼Å¨ÃÔ§äËÁ | 1 | | 0.50 |
| biomaker autistic | 1 | | 0.50 |
| ÁҵáÒäǺ¤ØÁÂÒÅ´¤ÇÒÁÍéǹ | 1 | | 0.50 |
| ¹ÒÂá¾·ÂìÍÀÔÃÑ¡Éì ÊѹµÔ§ÒÁ¡ØÅ | 1 | | 0.50 |
| âç§Ò¹¼ÅÔµà¡ÕêÂÇ«èÒ | 1 | | 0.50 |
| ÍÂ.˹éÒ·Õè | 1 | | 0.50 |
| ÇԷºÃÔ¡ÒÃËÁÒ¶֧ | 1 | | 0.50 |
| ¢Ñ鹵͹¡ÒüÅÔµ¹Á | 1 | | 0.50 |
| ÁҵáÒûéͧ¡Ñ¹ÂÒ»ÅÍÁ | 1 | | 0.50 |
| à¨éÒ˹éÒ·ÕèËéͧ¨èÒÂÂÒâç¾ÂÒºÒŹ¤Ã¾¹Á | 1 | | 0.50 |
| ÍØ»ÊÃä ¢Í§ºÃÔÉÑ·¡ÒúԹä·Â | 1 | | 0.50 |
| âºÇìªÑÇÃìâäÁҡѺ¹éÓ·èÇÁ | 1 | | 0.50 |
,
User's Guide
˹éÒÅçÍ¡ÍÔ¹| ʶԵÔÃÒ»Õ
| ʶԵÔÃÒÂà´×͹
| ʶԵÔÃÒÂÇѹ
| ʶԵÔÃÒªÑèÇâÁ§
| Eng
Pageview 
Unique IPs 
Sessions